Skip to main content

TRX Gold Reports Third Quarter 2026 Results

Record Throughput and Plant Expansion Drive Strong Performance and the Next Phase of Growth TORONTO, July 15, 2026 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX: TRX) (NYSE American: TRX) (the “Company” or “TRX Gold”) reported its results for the third quarter of 2026 (“Q3 2026”) for the three and nine months ended May 31, 2026. Financial results are available on the Company’s website at www.TRXgold.com. Unless otherwise noted, all references to currency in this press release refer to US dollars. TRX Gold’s CEO, Stephen Mullowney commented: “Our Q3 2026 results demonstrate that our investments in plant optimization are delivering measurable improvements and further reinforce the strength and scalability of our asset. Over the last twelve months (“LTM”) we have generated $115.5 million in revenues, adjusted EBITDA1 of $66.8 million...

Continue reading

ETC Announces Fiscal 2027 First Quarter Results

SOUTHAMPTON, Pa., July 15, 2026 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTCID: ETCC) (“ETC” or the “Company”) today reported its financial results for the thirteen week period ended May 29, 2026 (the “2027 first fiscal quarter”). Robert L. Laurent, Jr., ETC’s Chief Executive Officer and President stated, “We once again generated positive operating results and are especially pleased with the 17% increase in backlog vs. prior year driven by $39.5 million in contract awards during the 2027 first fiscal quarter. We are well positioned for continued positive results as we exit the quarter with a sales backlog of $85 million.” Fiscal 2027 First Quarter Results of Operations Net Income Net income was $0.2 million, or $0.01 diluted earnings per share, in the 2027 first fiscal quarter, compared to net income of $1.3 million...

Continue reading

Union Bankshares Announces Earnings for the three and six months ended June 30, 2026 and Declares Quarterly Dividend

MORRISVILLE, Vt., July 15, 2026 (GLOBE NEWSWIRE) — Union Bankshares, Inc. (NASDAQ – UNB) today announced results for the three and six months ended June 30, 2026 and declared a regular quarterly cash dividend. Consolidated net income for the three months ended June 30, 2026 was $2.9 million, or $0.61 per share, compared to $2.4 million, or $0.53 per share, for the same period in 2025, and $5.9 million, or $1.26 per share, for the six months ended June 30, 2026, compared to $4.9 million, or $1.08 per share, for the same period in 2025. President and Chief Executive Officer Jeffrey F. Weidley commented on the results: “Union Bankshares delivered strong second quarter and year-to-date results, reflecting the strength of our balance sheet, disciplined execution, and the dedication of our employees. Growth in net interest...

Continue reading

First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

First patients dosed in OPTIMAL-e1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on the OPTIMAL-PSMA2 study which recently completed patient enrollment. TLX597-Tx is Telix’s next generation PSMA3-targeting small molecule radioligand therapy candidate designed to improve efficacy and quality of life in earlier-stage prostate cancer.MELBOURNE, Australia and INDIANAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and St Vincent’s Hospital today announced that the first patients have been dosed with TLX597-Tx (177Lu-DOTA-HYNIC-panPSMA) in the OPTIMAL-e trial, led by Professor Louise Emmett for patients with metastatic...

Continue reading

Mont Sorcier Optimization Studies Delay Bankable Feasibility Study, Key ESIA filings Remains on Schedule

ROUYN-NORANDA, Quebec, July 15, 2026 (GLOBE NEWSWIRE) — Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC in the US), herein called Chibougamau, is pleased to report that Cerrado Gold Inc. (CERT-TSXV, CRDOF-OTCQX) (Cerrado) have elected to extend the completion date on the Bankable Feasibility Study at its Mont Sorcier high grade iron ore deposit in the Chibougamau region of Quebec where Chibougamau owns a 2% GMR royalty. Cerrado intends to review numerous optimization and trade off opportunities that have been identified during the BFS process as having the potential to materially enhance the overall value of the project. Highlights of the Optimization and Trade Off opportunities discussed in the Cerrado Gold press release.Optimization...

Continue reading

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 before market open on Tuesday, August 4th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/. About CertaraCertara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical...

Continue reading

RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer

ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) — RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D., who will continue to serve as Chief Medical Officer. Mr. Mottiwala brings extensive commercial leadership experience across eye care, with a proven track record of building and scaling high-performing commercial organizations. He most recently served as Chief Commercial Officer at Tarsus Pharmaceuticals and previously held the same role at Opiant Pharmaceuticals. Before that, he spent more than a decade at Allergan, where he held senior leadership positions across the company’s eye care franchise and broader commercial organization. Mr. Mottiwala holds a B.S. in Biochemistry...

Continue reading

Plexus Sets Fiscal Third Quarter 2026 Earnings Release Date

NEENAH, WI, July 15, 2026 (GLOBE NEWSWIRE) — Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal third quarter 2026 results after market close on Wednesday, July 29, 2026. Plexus’ management will host a conference call to discuss its fiscal third quarter 2026 results on Thursday, July 30, 2026 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com.What: Plexus Fiscal Q3 2026 Earnings Conference Call and WebcastWhen: Thursday, July 30, 2026 at 8:30 a.m. Eastern TimeWhere: Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below: Webcast link: https://events.q4inc.com/attendee/435522461Replay: The...

Continue reading

Richardson Electronics Announces Date of Fourth Quarter Fiscal Year 2026 Conference Call

LAFOX, Ill., July 15, 2026 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL) plans to release its financial results for its fourth quarter ended May 30, 2026 after the close of business on Wednesday, July 22, 2026. The release will be distributed by GlobeNewswire and will be available on the Company’s website at www.rell.com. On Thursday, July 23, 2026, at 9:00 a.m. Central Time, Edward J. Richardson, Chairman and Chief Executive Officer, and Robert J. Ben, Chief Financial Officer, will host a conference call to discuss the Company’s fourth quarter fiscal year 2026 results. A question-and-answer session will be included as part of the call’s agenda. Participant Instructions Participants may register for the call here. While not required, it is recommended you join 10 minutes prior to the event start. A replay of the...

Continue reading

Kish Bancorp, Inc. Reports Net Income of $5.3 Million, or $1.77 Per Share, for the Second Quarter of 2026

STATE COLLEGE, Pa., July 15, 2026 (GLOBE NEWSWIRE) — Kish Bancorp, Inc. (OTCQX: KISB) (“Kish” or the “Company”), parent company of Kish Bank, reported net income of $5.3 million, or $1.77 per share, for the second quarter of 2026, compared to $5.3 million, or $1.76 per share, for the first quarter of 2026, and $3.8 million, or $1.28 per share, for the second quarter of 2025. Results for the second quarter of 2026 included a $982 thousand provision for credit losses, compared to an $845 thousand provision expense in the first quarter of 2026, and a $470 thousand provision expense in the second quarter of 2025. For the first six months of 2026, net income was $10.6 million, or $3.51 per share, compared to $7.4 million, or $2.50 per share, for the six-month period in 2025. All results are unaudited. “Earnings momentum carried into...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.